Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
oleh: Priscilla C Hsu, Jane A Buxton, Andrew W Tu, Warren D Hill, Amanda Yu, Mel Krajden
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2008-01-01 |
Deskripsi
BACKGROUND: An estimated 60,000 British Columbians are chronically infected with the hepatitis C virus (HCV); 10% to 20% will develop cirrhosis after 20 years and 5% to 10% of these will develop hepatocellular carcinoma. Although treatment may prevent cirrhosis and liver cancer, and improve quality of life, availability is limited.